Global Glass Syringe Market is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2020-2027. Glass syringes are the most widely used in syringe pump applications. They are available in a variety of sizes including microliter volumes, enabling experiments with extremely small injection volumes. They are ideal for high precision work. In the recent years, there has been a surge in health issues due to unhealthy lifestyle of people and growth of healthcare sector is likely to contribute to the expansion of the global glass syringe market. Also, the use of plastic material for manufacturing syringes causes harm to environment and plastic syringes do not have the capacity to hold the highly sensitive drugs. But glass syringes can hold the high precision drugs without causing any harm to the drug. Moreover, COVID-19 vaccine distribution has led to a huge demand for syringes, especially glass syringes to hold the sensitive drug. This will lead to the growth of glass syringes market. In 2021, , UNICEF anticipates delivering over 1 billion syringes to support COVID-19 vaccination efforts and 620 million syringes that UNICEF will purchase for other vaccination programs against other diseases such as measles, typhoid and more. This is likely to boost the demand for syringes market. However, the presence of plastic and disposable syringes in the market impedes the growth of the market over the forecast period of 2020-2027. Also, due to the rising health issues and demand for non- reactive syringes which can hold highly sensitive drug is likely to drive the growth of the market.
The regional analysis of global Glass Syringe market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.North Americais the leading/significant region across the world in terms of market share owing tothe growing health issues in US due to unhealthy lifestyle and increasing diseases. Whereas,Europe is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.Factors such as rising cancer patients required considerable use of healthcare resources would create lucrative growth prospects for the Glass Syringe market.

Major market player included in this report are:
Ompi
Baxter BioPharma Solution
ROVI CM
Terumo(JP)
Vetter(DE)
Unilife Corporation(US)
Taisei Kako(JP)
Roselabs Group(IN)
ARTE CORPORATION(JP)
Weigao Group Medical Polymer(CN)
Zibo Minkang Pharmaceutical(CN)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Syringe Type
Disposable
Reusable
By Material Type
Borosilicate Neutral Glass
Surface Treated Borosilicate Glass
Soda Lime Glass
By Capacity
Up to 1 ml
1 ml to 5 ml
5 ml to 20 ml
Above 20 ml
By End Use
Hospitals
Research Laboratories
Drug Manufacturing
Clinical Research
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of the Global Glass Syringe Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors